+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Forecast 2024-2030- Product Image
Global Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Forecast 2024-2030- Product Image
Sale

Global Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896708
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pancreatic Cancer Therapeutics Market size was estimated at USD 4.67 billion in 2023, USD 5.14 billion in 2024, and is expected to grow at a CAGR of 9.95% to reach USD 9.09 billion by 2030.

Pancreatic cancer therapeutics encompass a variety of treatment modalities used to manage and combat pancreatic cancer, known for its aggressive nature and challenging prognosis. The therapeutic landscape for this malignancy includes surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and supportive care measures that aim to relieve symptoms and improve the quality of life for patients. The need for pancreatic cancer therapeutics is driven by the increasing prevalence of the disease, attributed to factors such as aging populations, lifestyle-related risk factors, and genetic predispositions.

Additionally, supportive government policies to expand access to affordable pancreatic cancer treatment have extended the scope and reach of the therapeutic options for patients. However, the complex reimbursement landscape and the inability of clinical trials to provide beneficial and credible results pose concerns about the accuracy and efficacy of the therapies. Moreover, there has been some significant progress in understanding the biology of the disease, resulting in the development of targeted therapeutics and personalized medicine approaches. These treatments are designed to interfere with specific pathways or mechanisms that promote the growth and spread of pancreatic cancer cells.

Regional Insights

The Americas region, particularly the United States and Canada, is characterized by the presence of a robust clinical pipeline, high healthcare expenditure, and several major pharmaceutical companies. Food and Drug Administration (FDA) has approved designations such as Fast Track, Breakthrough Therapy, and Orphan Drug to several pancreatic cancer drugs, which accelerates the regulatory approval process. European nations such as Germany, France, and the United Kingdom are characterized by the presence of heightened healthcare spending, advanced healthcare facilities, and favorable reimbursement policies. The European Medicines Agency (EMA) plays a pivotal role in endorsing new therapeutic options, positively impacting market growth.

Strong research collaborations between private and public entities drive innovation in cancer therapeutic research. In APAC countries such as China, Japan, India, and South Korea, there is a growing patient population and increasing awareness regarding cancer diseases, driving the need for therapeutic options. The increase in local generic drug production in countries such as India contributes to regional market dynamics.

Market Trends by Segment

  • Type: Need for rapid deployment of therapeutic options due to fast progression of exocrine pancreatic cancer
  • Product: Expanding number of approvals for chemotherapy treatment options
  • End-Use: Expanding presence of collaborations and R&D initiatives in research institutes for pancreatic cancer treatment

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Trishula Therapeutics Initiates Phase 2 Trial of TTX-030, an Anti-CD39 Antibody, in First Line Metastatic Pancreatic Cancer Patients

Trishula Therapeutics, Inc., a clinical-stage biotechnology company, revealed the initiation of a randomized Phase 2 trial to assess the efficacy and safety of TTX-030, an anti-CD39 antibody, for the treatment of metastatic pancreatic ductal adenocarcinoma patients. This trial is expected to evaluate the combination of TTX-030 with chemotherapy, either with or without budigalimab (an investigational anti-PD-1 antibody), as a first-line treatment option. The study aims to enroll approximately 180 patients worldwide and will primarily focus on assessing progression-free survival in a biomarker-enriched population.

Lisata Receives Orphan Drug Designation For Pancreatic Cancer Therapy

Lisata Therapeutics was granted orphan drug designation from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products for LSTA1, an investigational drug specifically designed to treat pancreatic cancer. LSTA1 aims to activate a novel uptake pathway, allowing co-administered or tethered anti-cancer drugs to penetrate solid tumors effectively. Non-clinical data collected by Lisata and its partners demonstrates the enhanced delivery of established and emerging cancer treatments, including immunotherapy, chemotherapy, and RNA-based therapies.

PanCAN Announces New & Advanced Research Investment

PanCAN committed an unprecedented USD 34 million to its research endeavors, and the funding facilitated the awarding of nine coveted research grants. The research grants emphasize the organization's role as a driving force for progress within the pancreatic cancer sphere, nurturing brilliant scientists proposing cutting-edge research and fostering mentorship for upcoming talent. This impressive array of grants underscores PanCAN's commitment to driving critical advanements and supporting innovative research to defeat pancreatic cancer.

Key Company Profiles

The report delves into recent significant developments in the Pancreatic Cancer Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Amgen Inc., Ascentage Pharma Group, Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, Carrick Therapeutics Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Faeth Therapeutics, Inc., FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., GenesisCare, GlaxoSmithKline PLC, Hetero Healthcare Limited, ImmunityBio, Inc., Innovent Biologics Inc., Johnson & Johnson Services, Inc., Lupin Limited, Merck & Co., Inc., Mitsubishi Heavy Industries, Ltd., NGM Biopharmaceuticals, Inc., NovalGen, Novartis AG, PanTher Therapeutics, Inc., Pfizer, Inc., RenovoRx, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Zentalis Pharmaceuticals, Inc.

This research report offers invaluable insights into various crucial aspects of the Pancreatic Cancer Therapeutics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of pancreatic cancer cases across the world
5.1.1.2. Government initiatives to expand access to pancreatic cancer treatment options
5.1.2. Restraints
5.1.2.1. Adverse drug recalls and difficulty in availing reimbursement options
5.1.3. Opportunities
5.1.3.1. Research initiatives and advancements to improve the efficacy of pancreatic cancer therapeutics
5.1.3.2. Approvals for pancreatic cancer therapy and orphan drug approvals for cancer treatment
5.1.4. Challenges
5.1.4.1. Limitations and complications of pancreatic cancer treatment options and lack of trained medical professionals
5.2. Market Segmentation Analysis
5.2.1. Type: Need for rapid deployment of therapeutic options due to fast progression of exocrine pancreatic cancer
5.2.2. Product: Expanding number of approvals for chemotherapy treatment options
5.2.3. End-Use: Expanding presence of collaborations and R&D initiatives in research institutes for pancreatic cancer treatment
5.3. Market Trend Analysis
5.3.1. Advancements in pancreatic cancer therapeutics in Americas region due to strong presence of key players and supportive regulatory landscape
5.3.2. Collaborative R&D activities by cancer research organization and improved support for clinical trials of novel therapies to elevate the advancements in pancreatic cancer therapeutics in the Asia-Pacific
5.3.3. Concerted efforts of researchers, funding agencies, and regulatory bodies catalyzing to delivering novel pancreatic cancer therapeutic solutions across EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Pancreatic Cancer Therapeutics Market, by Type
6.1. Introduction
6.2. Endocrine Pancreatic Cancer
6.3. Exocrine Pancreatic Cancer
7. Pancreatic Cancer Therapeutics Market, by Product
7.1. Introduction
7.2. Chemotherapy
7.3. Gene Therapy
7.4. Immunotherapy
7.5. Radiation Therapy
7.6. Surgery
7.7. Targeted Therapy
8. Pancreatic Cancer Therapeutics Market, by End-Use
8.1. Introduction
8.2. Cancer Centers/Clinics
8.3. Hospitals
8.4. Research Institutes
9. Americas Pancreatic Cancer Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pancreatic Cancer Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pancreatic Cancer Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Trishula Therapeutics Initiates Phase 2 Trial of TTX-030, an Anti-CD39 Antibody, in First Line Metastatic Pancreatic Cancer Patients
12.3.2. Lisata Receives Orphan Drug Designation For Pancreatic Cancer Therapy
12.3.3. PanCAN Announces New & Advanced Research Investment
12.3.4. Prestige Biopharma and Imagion Biosystems Sign Partnership Agreement to Develop Early Pancreatic Cancer Diagnosis Platform
12.3.5. TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation
12.3.6. Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics
12.3.7. Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy
12.3.8. FDA Grants Breakthrough Therapy Designation to Zenocutuzumab for NRG1+ Pancreatic Cancer
12.3.9. FDA Clears TME Pharma’s IND for Pancreatic Cancer Therapy Trial
12.3.10. GenesisCare Launches ViewRay MRIdian MRI-Guided Radiation Therapy System at Lee Health Regional Cancer Center
12.3.11. USD 3 Million National Grant to Fund Pancreatic Cancer Study
12.3.12. Leap Therapeutics Acquires Flame Biosciences
12.3.13. Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
12.3.14. Faeth Therapeutics Raises USD 47 million to Advance Clinical Trials for Cancer
12.3.15. AstraZeneca-Merck's Lynparza Wins EU Approval for Pancreatic Cancer
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PANCREATIC CANCER THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PANCREATIC CANCER THERAPEUTICS MARKET DYNAMICS
FIGURE 7. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PANCREATIC CANCER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PANCREATIC CANCER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PANCREATIC CANCER THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CANCER CENTERS/CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CANCER CENTERS/CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 55. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 58. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 59. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 60. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 61. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 66. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 89. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 94. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 95. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 100. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 107. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 110. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 111. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 112. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 143. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 146. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 147. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 148. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 163. DENMARK PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. DENMARK PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. DENMARK PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. DENMARK PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. DENMARK PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 168. DENMARK PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 169. EGYPT PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. EGYPT PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. EGYPT PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. EGYPT PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. EGYPT PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 174. EGYPT PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 175. FINLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. FINLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. FINLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. FINLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. FINLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 180. FINLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 181. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 186. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 187. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 192. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 199. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 204. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 217. NORWAY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. NORWAY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. NORWAY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. NORWAY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. NORWAY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 222. NORWAY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 223. POLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. POLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. POLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. POLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. POLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 228. POLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 229. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 234. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 253. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 258. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 271. TURKEY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. TURKEY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. TURKEY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. TURKEY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. TURKEY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 276. TURKEY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 289. PANCREATIC CANCER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 290. PANCREATIC CANCER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abbvie Inc.
  • Amgen Inc.
  • Ascentage Pharma Group
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • C.H. Boehringer Sohn AG & Co. KG
  • Carl Zeiss AG
  • Carrick Therapeutics Limited
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Faeth Therapeutics, Inc.
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • GenesisCare
  • GlaxoSmithKline PLC
  • Hetero Healthcare Limited
  • ImmunityBio, Inc.
  • Innovent Biologics Inc.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Merck & Co., Inc.
  • Mitsubishi Heavy Industries, Ltd.
  • NGM Biopharmaceuticals, Inc.
  • NovalGen
  • Novartis AG
  • PanTher Therapeutics, Inc.
  • Pfizer, Inc.
  • RenovoRx, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zentalis Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.09 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned34

Related Topics

Related Reports

Global Pancreatic Cancer Therapeutics and Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Pancreatic Cancer Therapeutics and Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 204 Pages
  • Global
From
Global Pancreatic Cancer Therapeutics and Diagnostics Market Report by Type, Application, and Region 2024-2032 - Product Image

Global Pancreatic Cancer Therapeutics and Diagnostics Market Report by Type, Application, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Global Pancreatic Cancer Treatment Market by Affected region (Endocrine, Exocrine), Type (Chemotherapy, Targeted Therapy) - Forecast 2024-2030 - Product Image

Global Pancreatic Cancer Treatment Market by Affected region (Endocrine, Exocrine), Type (Chemotherapy, Targeted Therapy) - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Pancreatic Cancer Therapeutics & Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Pancreatic Cancer Therapeutics & Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 182 Pages
  • Global
From
Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, By Test Type (Imaging Test, Biopsy, Blood Test, Others), By Cancer Type (Exocrine, Endocrine), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, By Test Type (Imaging Test, Biopsy, Blood Test, Others), By Cancer Type (Exocrine, Endocrine), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.